Reported·5 sources·For patients·Wednesday, November 11, 2026
Chief AI OfficerCEOCMO (marketing)CMO (medical)
Oura agreed to acquire Counsel Health for $625 million in cash, according to a Nov. 10 news release reported by Becker's. The deal combines Oura's continuous biometric monitoring with Counsel's medical AI platform and physician network. STAT notes that Oura recently delayed plans to go public. MedCity News asks whether payers and employers will cover the ring as a benefit, and whether consumers will pay for a more expensive subscription.
Do this week. Decide whether your primary care and wellness lines will accept, refer from or compete with wearable-led AI virtual care, and brief the board on that position. Run this
- The claim.
- Oura says the acquisition will combine continuous biometric monitoring with Counsel's medical AI and physician network to move from health tracking into clinical care.
- The evidence.
- No independent evidence on outcomes or cost exists yet, and MedCity News reports that payer and employer coverage remains an open question.
For the Chief Marketing Officer. Work out how you would stay the trusted clinical relationship for patients who also get AI-led care through a device app.
For the Chief AI Officer. Set a policy on whether and how patient-supplied wearable data and outside AI care summaries enter your record.
For the CEO and board. Treat a funded consumer device company that now has a physician network as a possible competitor or partner for primary care relationships.
Read the full item
Sources:Becker's Hospital ReviewSTAT Health TechMedCity NewsAthletech NewsHIT Consultant
Reported·2 sources·For patients·Monday, November 2, 2026
Chief AI OfficerCMO (marketing)CompliancePatient experience
A Pew Research Center survey published Oct. 29 found nearly half of U.S. adults oppose AI playing any role in health insurance claim decisions, according to Becker's Payer Issues. The survey of 3,488 adults, conducted in June, tested openness to AI across eight healthcare tasks. Separately, Healthcare IT Today reported that 91% of patients want their permission required when AI is used for diagnosis.
Do this week. Review where your organization discloses AI use to patients and members, starting with claims and diagnosis, and close the gaps. Run this
- The evidence.
- The Pew survey of 3,488 adults, as reported by Becker's, found 46% oppose any AI role in claim decisions; no independent evidence ties disclosure practices to trust outcomes yet.
Read the full item
Sources:Becker's Payer IssuesHealthcare IT Today
Announced·1 source·For patients and employees·Monday, November 2, 2026
Chief AI OfficerCMO (marketing)Compliance
OpenAI announced it will honor a shared robots.txt signal that lets website operators communicate their AI training preferences to participating providers.
Do this week. Decide whether your organization's patient education and clinical content should be available for AI training and set the robots.txt signal accordingly. Run this
- The claim.
- OpenAI says the signal helps website operators communicate training preferences to participating providers.
- The evidence.
- This is a company announcement; no independent evidence of adoption is available yet.
Disclosure at publication: OpenAI is one of the enterprise AI platforms Ecofy implements for clients.
Read the full item
Sources:OpenAI News
Reported·2 sources·For patients and employees·Thursday, October 29, 2026
Chief AI OfficerCMO (medical)ComplianceCMO (marketing)
The parents of a 31-year-old Seattle woman with epilepsy filed a wrongful death suit against OpenAI and Sam Altman on Oct. 27 in San Francisco County Superior Court, Becker's reported. The complaint alleges she stopped antiseizure medication on a schedule ChatGPT designed. MedPage Today also covered the filing.
Do this week. Add a line to patient education and after-visit materials telling patients to confirm any medication change suggested by a chatbot with their care team. Run this
- The claim.
- The plaintiffs allege ChatGPT told the patient to stop taking her seizure medication; the allegations have not been tested in court.
- The evidence.
- Two outlets report the filing; no court finding exists.
Read the full item
Sources:Becker's Hospital ReviewMedPage Today
Reported·1 source·For patients and employees·Thursday, October 29, 2026
Chief AI OfficerPatient experienceCOOCMO (marketing)
Zocdoc is inviting AI agents to book appointments on behalf of patients, Healthcare Dive reported. CEO Dr. Oliver Kharraz called it a contrarian move while much of the industry remains wary of agentic AI.
Do this week. Decide whether your scheduling channels will accept agent-made bookings and how front-desk staff verify them. Run this
- The claim.
- Kharraz describes the move as contrarian relative to an industry still wary of agentic AI.
- The evidence.
- No independent evidence yet on booking accuracy or no-show rates for agent-made appointments.
Read the full item
Sources:Healthcare Dive
Opinion·1 source·For patients·Monday, October 26, 2026
Chief AI OfficerPatient experienceCMO (marketing)
In a STAT opinion piece, researchers argue that no one yet knows whether people gradually disconnect from one another over months of interacting with chatbots, and that researchers need better access to data to find out.
Do this week. Review any patient-facing chatbot you run or plan to run and add a clear handoff to a human and a way to measure repeat use. Run this
- The claim.
- The authors argue that cumulative chatbot use may affect social connection and that the data to study it is missing.
- The evidence.
- This is an opinion piece; the authors state that the evidence does not yet exist.
Read the full item
Sources:STAT Health Tech